Senior US Soldier Based at NATO Headquarters Arrested on Suspicion of Helping RussiaNovember 11, 2026
Linda Taylor on October 23, 2026 7:41 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Robert I. Moore on October 23, 2026 7:44 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Elijah Williams on October 23, 2026 7:45 am I like the balance sheet here—less leverage than peers. Reply
Noah Moore on October 23, 2026 7:47 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Emma Thompson on October 23, 2026 7:47 am Silver leverage is strong here; beta cuts both ways though. Reply
Lucas Brown on October 23, 2026 7:47 am Interesting update on 16 Hours on 5 Pills of Ibogaine: Tu Lam’s Journey w/ Psychedelics. Curious how the grades will trend next quarter. Reply
Linda Johnson on October 23, 2026 7:48 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Elijah White on October 23, 2026 7:49 am Silver leverage is strong here; beta cuts both ways though. Reply
Jennifer Martin on October 23, 2026 7:50 am Interesting update on 16 Hours on 5 Pills of Ibogaine: Tu Lam’s Journey w/ Psychedelics. Curious how the grades will trend next quarter. Reply
Emma Lee on October 23, 2026 7:50 am Silver leverage is strong here; beta cuts both ways though. Reply
Liam N. Thompson on October 23, 2026 7:50 am Exploration results look promising, but permitting will be the key risk. Reply
Oliver Martin on October 23, 2026 7:50 am If AISC keeps dropping, this becomes investable for me. Reply
Michael Garcia on October 23, 2026 7:50 am Nice to see insider buying—usually a good signal in this space. Reply
Oliver Martin on October 23, 2026 7:51 am Interesting update on 16 Hours on 5 Pills of Ibogaine: Tu Lam’s Journey w/ Psychedelics. Curious how the grades will trend next quarter. Reply
John Jackson on October 23, 2026 7:52 am Nice to see insider buying—usually a good signal in this space. Reply
Mary W. Brown on October 23, 2026 7:53 am I like the balance sheet here—less leverage than peers. Reply
Liam F. Rodriguez on October 23, 2026 7:54 am Uranium names keep pushing higher—supply still tight into 2026. Reply
Ava Lee on October 23, 2026 7:54 am Uranium names keep pushing higher—supply still tight into 2026. Reply
John Martin on October 23, 2026 7:54 am Nice to see insider buying—usually a good signal in this space. Reply
Liam Thomas on October 23, 2026 7:55 am Interesting update on 16 Hours on 5 Pills of Ibogaine: Tu Lam’s Journey w/ Psychedelics. Curious how the grades will trend next quarter. Reply
By Mike Ritland
By Mike Ritland
By Mike Ritland
38 Comments
The cost guidance is better than expected. If they deliver, the stock could rerate.
The cost guidance is better than expected. If they deliver, the stock could rerate.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on 16 Hours on 5 Pills of Ibogaine: Tu Lam’s Journey w/ Psychedelics. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Interesting update on 16 Hours on 5 Pills of Ibogaine: Tu Lam’s Journey w/ Psychedelics. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Interesting update on 16 Hours on 5 Pills of Ibogaine: Tu Lam’s Journey w/ Psychedelics. Curious how the grades will trend next quarter.
Nice to see insider buying—usually a good signal in this space.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on 16 Hours on 5 Pills of Ibogaine: Tu Lam’s Journey w/ Psychedelics. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.